Faculty Directory
- Name
- Na Young Han
- Faculty Appointment
(title, department)
- Assistant Professor, Dept of Cancer AI & Digital Health
- Area of Expertise
- Digital Pathology
- E-mail
- hanny@ncc.re.kr
- Educational Background
-
Ph.D. Seoul National University College of Medicine (2016)
M.D. Seoul National University College of Medicine (2011)
- Research Interests
-
Doctor Nayoung Han is currently working as a medical doctor in the department of pathology of the National Cancer Center, Korea. She has been consistently working on practice and academic research in the field of pathology and digital health. She is also actively enrolled in many national projects about digital pathology and machine learning in Korea.
- Achievements
-
2022 Capecitabine and Temozolomide for Metastatic Intermediate to High-Grade Pancreatic Neuroendocrine Neoplasm: A Single Center Experience: KOREAN JOURNAL OF INTERNAL MEDICINE. 37(6):1216-1222
2022 Recurrent L3 Chordoma Presented as Intradural Extramedullary mass with Distant Metastasis: A case report: Brain Tumor Research and Treatment. 10(2):123-128
2022 Establishment of Patient-derived Preclinical Models for Invasive Papillary Cholangiocarcinoma: ANTICANCER RESEARCH. 42(1):599-608
2021 Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study: FRONTIERS IN IMMUNOLOGY. 12:715000
2021 RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin: JOURNAL OF CLINICAL MEDICINE. 10(20):4652
2020 Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers: CANCER RESEARCH AND TREATMENT. Online:Published
2020 The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters: BRITISH JOURNAL OF CANCER. 123(4):610-618
2019 PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms: JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE. 53(1):23-30
2018 Prognostic Value of Pathologic Chemotherapy Response Score in Patients With Ovarian Cancer After Neoadjuvant Chemotherapy: International journal of gynecological cancer. 28(9):1676-1682
2018 Multiple small, rectal neuroendocrine tumors with numerous micronests: Journal of digestive diseases. 19(9):572-575
2018 CT diagnosis of gallbladder adenomyomatosis: importance of enhancing mucosal epithelium, the "cotton ball sign": European radiology. 28(9):3573-3582
2018 Evaluation of Intratumoral and Intertumoral Heterogeneity of MET Protein Expression in Gastric Cancer: Applied immunohistochemistry & molecular morphology. 26(7):445-453
2016 Loss of ARID1A expression is related to gastric cancer progression, epstein-barr virus infection, and mismatch repair deficiency. Applied Immunohistochemistry & Molecular Morphology. 24(5):320-5.
2016 Meningeal solitary fibrous tumors with delayed extracranial metastasis. Journal of pathology and translational medicine. 50(2):113.
2015 Evaluation of Fibroblast Growth Factor Receptor 2 Expression, Heterogeneity and Clinical Significance in Gastric Cancer. Pathobiology. 82(6):269-79.
2014 Effects of fixation and storage of human tissue samples on nucleic Acid preservation. Korean journal of pathology. 48(1):36-42.
2014 Prognostic implication of TSC1 and mTOR expression in gastric carcinoma. Journal of surgical oncology. 109(8):812-7.
2013 DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value. Pathobiology. 81(1):25-35.
2012 Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology. 80(2):87-94.
